← Open Payments lookup

RUINING XU: Open Payments

NPI 1134957749 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$605 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $682 · 2025 $605

Food & beverage: $605
CompanyPaymentsAmount
Lilly USA, LLC3$157
Viatris Specialty LLC1$122
Gilead Sciences, Inc.1$109
SANOFI PASTEUR INC.2$70
Novo Nordisk Inc2$57
GlaxoSmithKline, LLC.1$28
Dynavax Technologies Corporation1$22
Amgen Inc.1$22
Exact Sciences Corporation1$17

Products named: MOUNJARO, YUPELRI, Vemlidy, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Ozempic, TRELEGY ELLIPTA, Heplisav-B.

Industry payments across CA — which companies pay providers there.